Maria Ekholm

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Breast cancer research and treatment

Breast cancer research : BCR

Cancers

Region Jönköping County

Lunds Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Region Jönköping County Sep 01 2014

Sweden

Consultant medical oncology :: Department of Oncology

Region Jönköping County Mar 01 2007 - Aug 31 2014

Sweden

Senior house officer :: Department of Oncology

Danderyds Sjukhus AB Aug 01 2005 - Feb 28 2007

Sweden

Senior house officer :: Department of Medicine

Danderyds Sjukhus AB Jun 15 2003 - Jul 31 2005

Sweden

House officer

Education History

Lunds Universitet Apr 01 2013 - Apr 20 2018

Sweden

PHD :: Clinical Sciences Lund, division of Oncology and Pathology

Publications

Kian Chin, Amalia H Landén, Anikó Kovács, Fredrik Wärnberg, Maria Ekholm, Per Karsson, Roger Olofsson Bagge
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast cancer research and treatment 207 (1) (2024)
Kian Chin, Amalia H Landén, Anikó Kovács, Fredrik Wärnberg, Maria Ekholm, Per Karsson, Roger Olofsson Bagge
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast cancer research and treatment 207 (1) (2024)
Kian Chin, Amalia H Landén, Anikó Kovács, Fredrik Wärnberg, Maria Ekholm, Per Karsson, Roger Olofsson Bagge
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast cancer research and treatment (2024)
Kian Chin, Amalia H Landén, Anikó Kovács, Fredrik Wärnberg, Maria Ekholm, Per Karsson, Roger Olofsson Bagge
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast cancer research and treatment 207 (1) (2024)
Una Kjällquist, Balazs Acs, Sara Margolin, Emelie Karlsson, Luisa Edman Kessler, Scarlett Garcia Hernandez, Maria Ekholm, Christine Lundgren, Erik Olsson, Henrik Lindman, Theodoros Foukakis, Alexios Matikas, Johan Hartman
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study. Cancers 14 (11) (2022)
Faye Coe, Vivek Misra, Yamini McCabe, Helen Adderley, Laura Woodhouse, Zaheen Ayub, Xin Wang, Sacha Howell, Maria Ekholm
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer. Breast cancer research and treatment (2021)
Sacha J Howell, Faye Coe, Xin Wang, Laura Horsley, Maria Ekholm
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP). Breast cancer research and treatment 184 (2) (2020)
Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up. Breast cancer research : BCR 22 (1) (2020)

Maria Ekholm.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maria Ekholm